The Life Science Companies involved in Clinical Trials are realizing the value of EDC. EDC allows the clinical team to review data in real-time which can result in “cleaner” data. Also, EDC allows The Medical Director/Monitor to assess the accuracy of the incoming data, review the patient safety profile and initiate discussions with the regulatory authorities as necessary. The aforementioned attributes are particularly important as we continue to conduct global clinical trials. During these challenging times and the increasing cost of drug and medical device development, EDC can decrease the time to collect data thus, reducing the study time and perhaps the cost of the study. The market currently consists of a number of Software providers, some that immediately come to mind are, Phase Forward, Medidata Solutions and Parexel (Predictive). Of course, there are others that you know and have experience with.
Creativity will identify the leaders of tomorrow ; that being said, I am sure other electronic tools will be developed and utilized in an effort to reduce development time and cost.